Lupus Foundation of America7h
New Study Finds Anifrolumab In Addition to Standard of Care Treatment is Effective at Reducing Organ Damage Accumulation
There are multiple chapters near you. Select your preferred chapter.
Too Old to Operate17h
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
For patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with less organ ...